Intervention

Enalapril

ClinicalTrials.gov intervention label

Clinical trials36

Recruiting2

Common conditions25

Lead sponsors shown15

Clinical trials

36 shown

Cardiovascular Protection After Preeclampsia With EnalaprilNCT07222852 · 2026-01-01

Bariatric Surgery and Pharmacokinetics of EnalaprilNCT03460366 · 2016-11-02

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)NCT07547878 · 2026-04-30

NOT_YET_RECRUITING

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection FractionNCT05487261 · 2022-12-13

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.NCT04853758 · 2021-05-06

Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum PeriodNCT04236258 · 2020-01-24

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCCNCT04023227 · 2019-12-10

COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart FailureNCT03917459 · 2019-04-16

H-Type Hypertension Precision Medicine TrialNCT03472508 · 2018-03-20

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?NCT03265574 · 2017-10-04

A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF PatientsNCT03066804 · 2017-08-22

The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart FailureNCT03190304 · 2017-06-14

Comparing ARNI With ACE Inhibitor on Endothelial FunctionNCT03119623 · 2017-06-01

randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart FailureNCT02900378 · 2016-12-20

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart FailureNCT02678312 · 2016-11-03

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection FractionNCT02874794 · 2016-08-17

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.NCT02768298 · 2016-07-12

Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.NCT02554890 · 2016-04-29

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection FractionNCT02468232 · 2015-06-15

Relative Bioavailability Study With Enalapril in Healthy VolunteersNCT02252692 · 2014-08-01

Mitigation of Radiation Pneumonitis and FibrosisNCT01754909 · 2013-11-01

Bevacizumab vs Dacarbazine in Metastatic MelanomaNCT01705392 · 2013-01-01

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of AgeNCT01151410 · 2010-08-01

Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential HypertensionNCT01093807 · 2010-03-01

Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in HumanNCT01069042 · 2010-02-01

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart FailureNCT00853658 · 2009-03-01

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)NCT00543413 · 2007-10-01

Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With HypertensionNCT00446511 · 2007-06-01

Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood PressureNCT00433836 · 2007-01-01

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs AloneNCT00391846 · 2006-10-01

Angiotensin Converting Enzyme Inhibition in Children With Mitral RegurgitationNCT00113698 · 2004-12-01

Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart NetworkNCT00113087 · 2003-08-01

Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart FailureNCT01411735 · 2003-07-01

Prevention of Chemotherapy-induced Cardiotoxicity in High-risk PatientsNCT00292526 · 2000-11-01

Telmisartan Compared With Enalapril in Elderly Patients With Blood HypertensionNCT02177461 · 2000-04-01

A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)NCT00882440 · 1990-12-01

Common conditions

Leading sponsors

Novartis Pharmaceuticals13 Brigham and Women's Hospital2 Merck Sharp & Dohme LLC2 University of Sao Paulo General Hospital2 AstraZeneca1 Baylor Research Institute1 Boehringer Ingelheim1 Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań1 Ethicare GmbH1 European Institute of Oncology1 Haukeland University Hospital1 National Cheng-Kung University Hospital1 National Heart, Lung, and Blood Institute (NHLBI)1 Norwegian University of Science and Technology1 RECORDATI GROUP1

Trial status mix

COMPLETED25

UNKNOWN5

RECRUITING2

TERMINATED2

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

PHASE316

PHASE414

PHASE25

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.